Accuracy of Lymph Node Imaging in Prostate Cancer: PSMA PET-CT and Nano-MRI

NCT03223064 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Lymph Node Metastases

Interventions

DIAGNOSTIC_TEST: Ferumoxtran-10 enhanced MRI; MRI contrast agent
DIAGNOSTIC_TEST: 68Ga PSMA PET-CT

Sponsor

Radboud University Medical Center

Collaborators

[object Object]
[object Object]
[object Object]